|
HS Code |
391114 |
| Name | Glycyl-L-Aspartic Acid |
| Synonyms | Gly-Asp, Glycylaspartate |
| Chemical Formula | C6H10N2O5 |
| Molecular Weight | 190.15 g/mol |
| Cas Number | 23541-22-8 |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Conditions | Store at 2-8°C, protected from light |
| Peptide Sequence | Gly-Asp |
| Iupac Name | 2-[(2-aminoacetyl)amino]succinic acid |
As an accredited Glycyl-L-Aspartic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of Glycyl-L-Aspartic Acid; sealed, labeled with product name, lot number, and safety information. |
| Shipping | Glycyl-L-Aspartic Acid is shipped in tightly sealed containers to protect from moisture and contamination. It should be kept in a cool, dry place, away from direct sunlight and incompatible substances. Standard shipping practices for non-hazardous laboratory chemicals are followed, ensuring safe and stable transport during transit. |
| Storage | Glycyl-L-Aspartic Acid should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible substances. Keep it in a tightly sealed container, preferably under refrigerated conditions (2–8°C) to maintain stability and prevent degradation. Avoid exposure to moisture and corrosive materials. Proper labeling and adherence to laboratory safety protocols are essential for safe storage. |
Applications of Glycyl-L-Aspartic Acid in Industrial ManufacturingGlycyl-L-Aspartic Acid plays a precise functional role in a range of advanced manufacturing flows, valued for its peptide structure and specific chelating and stabilizing capabilities. Our factory-direct material supports established industrial protocols and documented downstream process needs requiring traceable production, consistent input quality, and regulatory alignment. 1. Peptide-Based Cell Culture Media ProductionIndustrial peptide-based supplements for cell culture media frequently require Glycyl-L-Aspartic Acid, where it enhances nutrient delivery and optimizes chelation of essential ions without introducing undefined components. Manufacturers select Glycyl-L-Aspartic Acid to maintain performance consistency across serialized batch production while staying within compliance for biologics manufacturing intended for direct and indirect pharmaceutical and biotechnological applications. Precise handling of the ingredient during amino acid blending, filtration, and system filling safeguards batch traceability and minimizes contamination risks in high-grade and cGMP-compliant environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Specialty Peptide Synthesis for Active Pharmaceutical Ingredients (APIs)Leading peptide contract manufacturers employ Glycyl-L-Aspartic Acid as a protected dipeptide building block for solid-phase and solution-phase peptide synthesis, streamlining stepwise chain assembly and simplifying protecting group strategies. The unique sequence supports the generation of therapeutic peptides and diagnostic probes, ensuring reproducibility and compliance for submission batches. Strict process control yields APIs that meet global pharmacopeial standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chelating Agent in Cosmetic FormulationsIn the cosmetic industry, formulation chemists add Glycyl-L-Aspartic Acid into high-end skincare and personal care products to sequester metal ions, supporting formula stability and improving shelf-life under harsh storage conditions. Its peptide-based nature offers an alternative to EDTA in certain regulatory markets focused on ingredient biodegradability or natural-origin claims. Usage is controlled to balance efficacy without affecting skin compatibility or sensorial properties, maintaining alignment with regional and international cosmetic regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Additive in Biomedical Diagnostic ReagentsProducers of in vitro diagnostic (IVD) kits integrate Glycyl-L-Aspartic Acid to stabilize enzyme-based assay buffers and maintain consistent signal calibration for quantitative tests. The peptide’s ion chelating properties prevent signal drift due to trace contaminants or metal-catalyzed enzyme inactivation, ensuring the reliability of critical test batches from pilot scale to high-volume manufacturing. All formulation steps with the ingredient align with traceability and cleanroom requirements for regulatory approval in major healthcare markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Peptide-Based Corrosion Inhibitor for Industrial Water TreatmentEngineers in industrial water treatment apply Glycyl-L-Aspartic Acid in closed-system formulations to reduce scale formation and metal surface corrosion, particularly in facilities requiring environmentally responsible and low-toxicity additive packages. By incorporating this dipeptide, operators replace traditional aminopolycarboxylates in moderate-temperature circuits or sensitive process loops. The typical dosage aligns with permissible limits set by environmental authorities, ensuring non-interference with downstream biological treatment or recycling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Glycyl-L-Aspartic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Decades of work on oligopeptide synthesis put us in a unique position and we see Glycyl-L-Aspartic Acid with a clear eye: not just formula on the page, but a product that answers real needs in research and production. Its growth in popularity goes hand-in-hand with a broader interest in dipeptides with well-balanced properties, both chemically and physically. Glycyl-L-Aspartic Acid, with a CAS number of 3061-93-4, brings a very specific blend of stability, reactivity, and hydrophilicity. Many researchers first encounter this compound while looking for a reliable spacer or linker in peptide synthesis, but its value does not end there. Bench experience reveals even more practical uses once you get your hands on the actual material.
We produce Glycyl-L-Aspartic Acid in white crystalline powder form, with purity tailored to each batch, typically reaching above 98% (HPLC). Moisture content sits well below the 0.5% threshold. Our standard model rests on batch scales ranging from 10 grams (for development projects or analytic studies) up to multi-kilogram runs suited for industrial work. Rigorous controls leave trace metals and heavy elements at levels too low to skew bioactivity assays or pharmaceutical research. Each lot carries a full spectrum chromatographic printout, so you know exactly what you have in your hands, not just a ballpark figure from a spec sheet.
The molecular formula, C6H10N2O5, and molar mass of 190.15 g/mol, keep the compound straightforward in terms of handling, typically dissolving in water and various buffer systems. Our production lines run under ISO-guided protocols because biochemistry and peptide synthesis developers expect more than generic chemical suppliers can provide. Consistency from lot to lot is measurable, and it's a direct result of investing in our own reactors, rather than outsourcing or buying generic material and slapping on a private label.
Our earliest large-scale customers came from peptide drug development, where the repeatability of synthesis steps makes or breaks a project’s timeline. Glycyl-L-Aspartic Acid, as an intermediate, rarely gives purification headaches thanks to its good solubility and robust resistance to racemization. The aspartic acid side chain introduces sites for hydrogen bonding and allows for predictable folding and interaction. Peptide chemists, both at the bench and in process scale-up, spot it as a workhorse for building out longer, functionally diverse chains.
We learned quickly to talk with formulators in biotech—who pointed out that the product does not just sit in a bottle, but gets blended, dissolved, and exposed to heat and agitation. Glycyl-L-Aspartic Acid stands up under prolonged stirring and mild heating, showing minimal degradation. These small details matter during scale-up and purification.
Beyond classic peptide synthesis, we see it used as a chelating agent because of the aspartic acid moiety. A handful of biomedical groups use it in design studies for enzyme inhibitors and cell-signaling modulators. Fragments like this allow controlled testing of charge and hydrophobicity distribution in synthetic biology. Analytical labs interested in calibration standards for mass spectrometry find that it ionizes with high reproducibility, so reference curves are less likely to shift batch-to-batch.
Shelf stability means we can send product by air, sea, or truck without worrying about temperature excursions or loss of function—something that has made life easier for procurement managers under pressure to cut logistics costs. In short, every aspect of Glycyl-L-Aspartic Acid’s behavior comes from choices made at the synthesis and purification steps, not from marketing spin. If a peptide project runs into solubility issues or unpredictable reactivity, attention always circles back to small but critical details upstream, where we have direct hands-on control of process parameters.
Discussions with both university labs and global pharma groups show us that this compound faces competition from dozens of other dipeptides, each with specific features. What sets Glycyl-L-Aspartic Acid apart is its blend of manageable reactivity, hydrophilic footprint, and the way it opens the door to side-chain chemistry without excess steric hindrance. It’s not a single-use product, as some believe—applications multiply as end-users get familiar with its handling and integration into workflows. Several comparative studies using HPLC and NMR show minimal contaminant carryover during coupling reactions.
Working side-by-side with R&D chemists taught us that even small shifts in formulation, particle size, or pH stability change reactions down the line. For Glycyl-L-Aspartic Acid, our integrated production keeps batch-to-batch variation tight, so unpredictable shifts in synthetic efficiency, which often haunt material sourced from less controlled channels, rarely show up. Feedback from contract manufacturers who prepare APIs point out fewer troubleshooting calls and less downtime when using lots made in our reactors.
Sourcing basic peptide blocks often means gambling with traces of racemization, micro-impurities, or unwanted side reactions. Glycyl-L-Aspartic Acid sidesteps these problems because we control every process step ourselves, from raw amino acid sourcing right through coupling, crystallization, and final drying. Peptide chemists repeatedly flagged issues with unreliable intermediates from non-manufacturer suppliers: variability in solubility, hidden heavy metal content, and changes in reactivity.
We run each new batch against our reference materials. We use in-house HPLC, NMR, and mass spectrometry screening before anything leaves the plant. Veteran users notice the difference during purification—they can skip extra steps or avoid costly resin-based cleanups because residues and odd peaks don’t show up in our material. By talking face-to-face with synthetic labs, we keep improving on purity and performance metrics that matter in day-to-day application, not just theoretical analysis.
Dipeptides seem simple on paper. Yet swapping even a single residue transforms chemical and physical behavior. Glycyl-L-Aspartic Acid sits in a sweet spot—glycine end grants flexibility and low steric clash, aspartic acid provides a clear spot for further derivatization or additional charge. Use a dipeptide like Ala-Asp or Gly-Glu and you’ll see different solubility and coupling kinetics. Most users who settle on Glycyl-L-Aspartic Acid started by running side-by-side experiments and landed on it through practical trial, not abstract calculation.
Aspartic acid lends a unique profile to synthetic options. The secondary carboxyl allows for branching, double labeling, or controlled cyclization—try these approaches with Glycyl-L-Glutamic Acid and the extra methylene in glutamic acid can change folding behavior or binding. Experience on the line tells us Glycyl-L-Aspartic Acid’s reactivity window follows a predictable path, with less risk of byproduct formation even in longer reaction chains. Protein chemists carrying out labeling, immobilization, or bioconjugate work hit fewer snags than with similar dipeptides because of this selectivity.
Handling and storage logbooks confirm stability outstrips more reactive hydroxy- or amide-substituted dipeptides. For analytical standards, the backbone fragment mass matches commonly used ion traps and chromatographs without atypical fragmentation patterns. Academic labs have pointed out fewer ghost peaks or unexplained artifacts in peptide mapping studies, which saves guesswork downstream.
Direct production means we field technical questions from both senior researchers and new grad students. We encourage open feedback—a practice that sharpens process efficiency on our end and clarifies project setup for users. With Glycyl-L-Aspartic Acid, researchers have tested diverse applications: scaffold building for custom peptide arrays, materials science approaches embedding the dipeptide into functional coatings, even metalloprotein mimicry. Our process has adapted to each new need without requiring major overhauls or new hazard controls.
This adaptability grows from our investment in the physical plant and analytical tools. Double-column chromatography, controlled atmospheres, and final material storage below -20°C give a reassuring baseline, especially for regulated industries like pharma and diagnostics. We see users gaining trust with each repeat batch, since purity, moisture, and reactivity don't jump around between shipments.
A chemical isn’t just a line item. In Glycyl-L-Aspartic Acid’s case, the market evolved from low-volume, high-purity demand to broader applications in polymer science, diagnostics, and even agricultural biochemistry. Customers depend on accurate documentation, reliable process traceability, and lot release data upon request—something we've automated, but always back up with a real person ready to answer technical queries. This clarity prevents miscommunication and project stalls.
Feedback cycles with R&D teams lead us to tweak drying, adjust filtering approaches, and keep particle size consistent, especially for customers preparing precise solutions or automated dispensers. Rather than pushing generic material, we emphasize alignment with the specific hands-on use case for each loadout, based on data and user reports from sectors ranging from discovery chemistry to preclinical manufacturing.
Every kilo produced carries a backstory of incremental adjustments. Changes in crystallizer speed, wash solvent grade, or drying temperature ripple through downstream handling and application. Engineers working with us found that precise, nursemaid-level care in finishing stages paid off with improved reproducibility in thin-film casting, microanalysis, and batch-wise synthesis.
Our batch records stretch back years. Users investigating a spike in reactivity or off-spec color can get root-cause traceability. We avoid the common "commodity peptide" pitfalls—material that ships with a vague certificate, cut corners on washing, or loosely packed bags—all issues that come back to haunt users months later in troubleshooting costs.
Some buyers try bargain sources and wind up chasing variances for months. In our direct experience, these headaches—batch-to-batch changes, poor packaging, unexplained impurities—choke productivity and pile up hidden costs. Tight relationships with peptide manufacturers, diagnostic kit assemblers, and molecular medicine developers allow us to build continuous improvement into both the product and how it lands on a customer's workbench.
Growing demand for Glycyl-L-Aspartic Acid, especially in regulated sectors, brings pressure to tighten tolerances and hit stricter analytical thresholds. We've addressed this by investing in in-line QC stations, doubling up on final purity and moisture checks, and dedicating test runs for every batch released into pharmaceutical markets. Direct feedback highlights where product labels, technical bulletins, or COAs fall short—and we close these gaps not with generic downloads but with detailed, real-data reporting, usually delivered in parallel with shipments.
Shipping and storage present constant hurdles. A few years ago, international users reported material clumping after long sea transits, traced to humidity pick-up in subpar packaging. This led us to overhaul inner lining materials and strengthen vacuum sealing procedures. These changes led to smoother dissolutions and more consistent reconstitution for all customers.
Language barriers and time zones once slowed technical support for critical launches. We streamlined responses with direct chemist-to-user email exchanges and improved clarity on translated documents. The impact: fewer lost projects due to confusion or clock lag.
Most critical process improvements arise from actual usage, not theoretical models. Our drive to keep up with sector needs for Glycyl-L-Aspartic Acid means fielding requests for finer grade, higher purity, or different packaging almost every quarter. Rather than resisting, we build these requests into production schedules, seeing each as a way to sharpen both the science and practical usability for all users.
Advanced applications—like coupling to fluorescent tags, site-specific enzymatic assembly, or synthetic cell membranes—now come from developers using Glycyl-L-Aspartic Acid as a foundation, not just as a background reactant. Each use case teaches us more about required purity, stability, and processability—technical demands that most supply channels can't keep pace with unless they're tied closely to manufacturing, as we are.
Our perspective comes not only from synthesis experience, but from long-term follow-up with users in many settings. Glycyl-L-Aspartic Acid will only grow in utility as more sectors draw on its easy handling and broad compatibilities. Our experience shows that high standards at source, open feedback channels, and transparency in analytical data pay the most enduring dividends—both for users who rely on the product and for us, driving continuous improvement in every new batch.
Years of direct manufacturing teach that the difference in a research project’s outcome can rest on the consistency, purity, and traceability of something as "simple" as a dipeptide. Our day-to-day focus remains fixed on keeping Glycyl-L-Aspartic Acid not only reliable from a technical perspective, but also adaptable for all the creative and high-impact applications that scientists push it into next. By holding the production and analytics reins ourselves, we deliver what the market asks for, not just what fits an off-the-shelf mold.